Study register · detail
Clear benefit
GRADE
Low
93 citations
Samplen = 3.133.968 Pat.
Durationlongitudinal, up to 10–15 years…
ControlIndividuals without substance abuse…
EndpointSchizophrenia incidence
Blindingn.a.
DesignNationale Kohortenstudie (Registerbasiert)
Key finding
Substance abuse, particularly of cannabis and alcohol, is associated with a significantly increased risk of schizophrenia.
Summary
Nationwide Danish registry study (n=3.133.968 individuals, 105.178.673 person-years): cannabis abuse diagnosis increased the risk of developing schizophrenia to HR=5,20 (95% CI 4,86–5,57); strongest association of all substances (alcohol HR=3,38). Risk remained significant 10–15 years after substance abuse diagnosis; adjustment for sex, urbanicity, co-abuse, psychiatric history, parental substance abuse and socioeconomic status.
P
PopulationDanish general population, n=3.133.968, of which 204.505 with substance abuse diagnosis and 21.305 with schizophrenia diagnosis
I
InterventionSubstance abuse (cannabis, alcohol, hallucinogens, sedatives, among others) as exposure variable
C
ControlIndividuals without substance abuse diagnosis
O
OutcomeSubstance abuse overall HR 6,04 (95%-CI 5,84–6,26); cannabis HR 5,20 (95%-CI 4,86–5,57); alcohol HR 3,38 (95%-CI 3,24–3,53); all associations significant, also 10–15 years after substance abuse diagnosis
Confidence in the evidence
Low
The second of four GRADE levels, the effect estimate is of limited reliability.
Quality profile
Sample size
★★★★★
Blinding
—
Effect size
Clear benefit
Citations / year
★★★★★
Authors
Share
Abstract
<h4>Background</h4>Several studies have examined whether use of substances can cause schizophrenia. However, due to methodological limitations in the existing literature (e.g. selection bias and lack of adjustment of co-abuse) uncertainties still remain. We aimed to investigate whether substance abuse increases the risk of developing schizophrenia, addressing some of these limitations.<h4>Method</h4>The longitudinal, nationwide Danish registers were linked to establish a cohort of 3 133 968 individuals (105 178 673 person-years at risk), identifying 204 505 individuals diagnosed with substance abuse and 21 305 diagnosed with schizophrenia. Information regarding substance abuse was extracted from several registers and did not include psychotic symptoms caused by substance abuse in the definition. This resulted in a large, generalizable sample of exposed individuals. The data was analysed using Cox regression analyses, and adjusted for calendar year, gender, urbanicity, co-abuse, other psychiatric diagnosis, parental substance abuse, psychiatric history, immigration and socioeconomic status.<h4>Results</h4>A diagnosis of substance abuse increased the overall risk of developing schizophrenia [hazard ratio (HR) 6.04, 95% confidence interval (CI) 5.84-6.26]. Cannabis (HR 5.20, 95% CI 4.86-5.57) and alcohol (HR 3.38, 95% CI 3.24-3.53) presented the strongest associations. Abuse of hallucinogens (HR 1.86, 95% CI 1.43-2.41), sedatives (HR 1.68, 95% CI 1.49-1.90), and other substances (HR 2.85, 95% CI 2.58-3.15) also increased the risk significantly. The risk was found to be significant even 10-15 years subsequent to a diagnosis of substance abuse.<h4>Conclusion</h4>Our results illustrate robust associations between almost any type of substance abuse and an increased risk of developing schizophrenia later in life.
The impediment to action advances action.